JPMORGAN CHASE & CO - CARDIFF ONCOLOGY INC ownership

CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 89 filers reported holding CARDIFF ONCOLOGY INC in Q4 2021. The put-call ratio across all filers is 2.43 and the average weighting 0.2%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of CARDIFF ONCOLOGY INC
ValueSharesWeighting
Q3 2023$24,400
+64110.5%
17,554
+67415.4%
0.00%
Q2 2023$38260.0%0.00%
Q1 2023$0260.0%0.00%
Q4 2022$0260.0%0.00%
Q3 2022$0260.0%0.00%
Q2 2022$0
-100.0%
26
-99.9%
0.00%
Q1 2022$44,000
-62.7%
17,887
-9.4%
0.00%
Q4 2021$118,000
-9.2%
19,733
+1.4%
0.00%
Q3 2021$130,000
+7.4%
19,456
+7.6%
0.00%
Q2 2021$121,000
+245.7%
18,078
+384.0%
0.00%
Q1 2021$35,000
-2.8%
3,735
+86.7%
0.00%
Q4 2020$36,0002,0010.00%
Other shareholders
CARDIFF ONCOLOGY INC shareholders Q4 2021
NameSharesValueWeighting ↓
ELKHORN PARTNERS LIMITED PARTNERSHIP 45,000$630.04%
FinDec Wealth Services, Inc. 16,000$22,2400.02%
DENVER WEALTH MANAGEMENT, INC. 18,235$25,3470.02%
Atom Investors LP 18,298$25,4340.01%
Laurion Capital Management LP 722,100$1,003,7190.01%
Callan Capital, LLC 31,147$43,2940.01%
MAI Capital Management 224,749$312,4010.01%
GSA CAPITAL PARTNERS LLP 25,975$360.00%
Tortoise Investment Management, LLC 15,000$20,8500.00%
America First Investment Advisors, LLC 4,000$5,5600.00%
View complete list of CARDIFF ONCOLOGY INC shareholders